SEPTInvestingStart Free

ENGN SCHEDULE 13G: SEC filing

Eventide Asset Management, LLC

Filed with the SEC on · accession 0001580642-26-007717

ENGN filed a SCHEDULE 13G (schedule 13g) with the SEC on Nov 13, 2026. Eventide Asset Management, LLC filed a Schedule 13G reporting beneficial ownership of 3,406,023 common shares of enGene Therapeutics Inc., representing 5.1% of the outstanding shares, as of September 30, 2026. The stock moved +5.7% by the first close after the filing.

Summary of the filing

Eventide Asset Management, LLC filed a Schedule 13G reporting beneficial ownership of 3,406,023 common shares of enGene Therapeutics Inc., representing 5.1% of the outstanding shares, as of September 30, 2026. The filing is a passive investment disclosure under Rule 13d-1(b).

For details, click here →

Key details

Common shares beneficially owned$3.4M
Percentage of outstanding common shares owned$5
Filer / beneficial ownerEventide Asset Management, LLC
IssuerenGene Therapeutics Inc.
Registered investment company holding the sharesEventide Healthcare & Life Sciences Fund
Authorized signatory / control personFinny Kuruvilla, M.D., Ph.D.
Authorized signatory / control personRobin C. John
General counsel, eventide asset management, llcPeter J. Luiso

How ENGN stock reacted

Close before

$2.28

Nov 12, 2026

First close after

+5.70%

$2.41

5 trading days

—

Since filing

—

✦ Ask GOAX AI about this filing — what it means for ENGN, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for ENGN?

Click here

Frequently asked questions

What did ENGN file with the SEC on Nov 13, 2026?

ENGN filed a SCHEDULE 13G (SEC filing). Eventide Asset Management, LLC filed a Schedule 13G reporting beneficial ownership of 3,406,023 common shares of enGene Therapeutics Inc., representing 5.1% of the outstanding shares, as of September 30, 2026. The filing is a passive investment disclosure under Rule 13d-1(b).

How do I read a SCHEDULE 13G?

A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G (schedule 13g): A report the company filed with the SEC (the US market regulator).

How did ENGN stock react to this filing?

ENGN closed at $2.28 before the filing and $2.41 on Nov 13, 2026 (+5.70%).

Other ENGN SEC filings

Get alerts when ENGN files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days
ENGN overviewENGN analysisENGN newsLatest SEC filings